Blog
Images
- performance standard development
21 CFR Part 861
- classification
21 CFR Part 860
- Postmarket Surveillance
- PMS
21 CFR Part 822
- medical device tracking
- UDI
21 CFR Part 821
- q-sub
- pre-sub
Pre-Submission - Q-Sub
- substantially equivalent
Predicate Device
- premarket approval
- PMA
21 CFR Part 814
- premarket notification
- 510K
- PMN
21 CFR Part 807
- Investigational Device Exemptions
21 CFR Part 812
- Reports of Corrections & Removals
21 CFR Part 806
- Labeling
- Labels
21 CFR Part 801
Proposed 2023 LDT Rule
- 21 CFR Part 11
- electronic signatures
- electronic records
21 CFR Part 11
- 21 CFR Part 820
- QSR
- GMP
21 CFR Part 820
- Medical Device Reporting
21 CFR Part 803
- IVD
- label
- labelling
21 CFR Part 809
- preemption
- exemptions
21 CFR Part 808
- registration
- listing
21 CFR Part 807
- recall authority
- cease distribution order
- mandatory recall order
21 CFR Part 810
- traceability
- identification
Traceability
- TPLC
- cybersecurity
Cybersecurity - TPLC
- security risk management
- cybersecurity
Cybersecurity Security Risk Management Documentation
- anomalies
- cybersecurity
Cybersecurity Unresolved Anomalies
- SBOM
- cybersecurity
- submission
Documentation of Software Bill of Materials
- SBOM
- cybersecurity
Software Bill of Materials
- 3rd Party Software
- cybersecurity
Cybersecurity - 3rd Party Software Components
- threat modeling
- cybersecurity
Cybersecurity Threat Modeling
- security risk manamgent
Cybersecurity Security Risk Management
- SPDF
- cybersecurity
Cybersecurity SPDF
- submission documents
- cybersecurity
Cybersecurity Submission Documentation
- transparency
- cybersecurity
Cybersecurity - Transparency
- cybersecurity
- designing for security
Cybersecurity - Designing for Security
- cybersecurity
- design control
Cybersecurity in Design Control
- medical device system
- pre-sub
Cybersecurity in Medical Devices – Background
- scope
- pre-sub
Cybersecurity in Medical Devices- Scope
- cybersecurity threat
Cybersecurity in Medical Devices- Overview
- CFR
- regulation
Reading CFR
- VALID Act
Conditions of Approval and Approval Publication
- VALID Act
Amending An Application
Prognostic Biomarker
Predictive Biomarker
Safety Biomarker
Monitoring Biomarker
Response Biomarker
Pharmacodynamic (Response) Biomarker
Surrogate Endpoint (Response) Biomarker
- VALID Act
VALID Act Pre-Market Review Application
- VALID Act
Approval Process Go-No-Go Factors
Special Pre-Market Review
- VALID Act
00086 VALID Act Refused Or Deficient Application
- VALID Act
Pre-Market Review Requirement
- VALID Act
- exemption
General Laboratory Equipment Exemption
- VALID Act
Buying and Selling IVCTs and Notifications
- exemption
Investigational Use Exemption
- VALID Act
Modified Tests
- exemption
Parts and Components for Further Development
LDT Jurisdiction Debate
Diagnostic Biomarker
Susceptibility/Risk Biomarker
Biomarker Types by Disease Progress
- Exemption
Public Health Surveillance Exemption
Manual Test Exemption
- humanitarian test exemption
Humanitarian Test Exemption
Custom & Low-Volume Test Exemption
- near-patient
Near-Patient Testing Guidance
- exemption
Law Enforcement and Employer Testing Exemption
- Grandfathered Tests
VALID Act: Grandfathered Tests
- EUA in VALID Act
Emergency Use Authorization
- exemption disagreement
Developer Disagreement about IVCT Exemption
- breakthrough
- priority review
Breakthrough Devices
- well-established
- well-recognized
Well-Characterized
- interstate
- commerce
- in vitro clinical test
Interstate Commerce
- specimen receptacle
Specimen Receptacle
- cross-referenced
- medical products
Cross-Referenced Test
- Scientific Evidence
Valid Scientific Evidence
- Technology
IVCT Technology
- Instrument Family
- VALIID Act
Instrument and Instrument Family
- Developer
- Laboratory Operations
Developer vs Laboratory Operations
- IVCT Risk Classification
Low-Risk vs. High-Risk IVCT
- VALID Act
- IVCT
- FD&C Section 587
VALID Act: Overview
- First-of-a-kind
- IVCT
First-Of-A-Kind IVCT
- IVCT definition
IVCT Definition
- admin changes
- non-significant
Non-Significant Administrative Changes for MDR-IVDR
- EMDN
- CDN
EMDN Nomenclature Hierarchy & Example
- GMDN
- EMDN
- CDN
Nomenclature
- CAR T Cell
- Development
- FDA Draft Guidance
CAR T Cell Development
- CAPA
CAPA Management
- SaMD Category
Criteria for Determining SaMD Category
- quality assurance
- quality control
QA vs QC
- investigational product
- LDT
- CTA
IVD vs LDT vs CTA vs Investigational Product
- Investigational IVD
- 21 CFR Part 812
- IDE
Investigational IVD Types
- companion diagnostic
Companion Diagnostic
- codevelopment
- companion diagnostics
Codevelopment
- combination product types
Combination Product Types
- combination product
Combination Product
State of the Art
- ISO 19471:2019
- risk management
- risk process
14971-2019 Risk Management Process Overview
- NextSeq
- instrument
- sequencer
NextSeq 550
- manufacturers
- IVD
IVD Manufacturers
Requests Welcome
Can’t find what you are looking for? Leave a message in the comments page.